Pablo Peña-Martinez

8PUBLICATIONS
33CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Innate immunityCancer cell biologyHaematological tumoursCell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 25, 2025
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Henrik Lilljebjörn, Pablo Peña-Martínez, Hanna Thorsson

|Oct 03, 2025
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Carl Sandén, Niklas Landberg, Pablo Peña-Martínez

|Dec 18, 2024
Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment.

Nils Hansen, Pablo Peña-Martínez, Petter Skoog

|Jul 05, 2024
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Hanna Thorsson, Rasmus Henningsson, Noelia Puente-Moncada

|Jul 28, 2023
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Maria Rodriguez-Zabala, Ramprasad Ramakrishnan, Katrin Reinbach

|Nov 16, 2022
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez

Pageof 2

Frequent Collaborators

5 joint publications

Carl Sandén

4 joint publications

Henrik Lilljebjörn

4 joint publications

Niklas Landberg

4 joint publications

Vladimir Lazarevic